Magnitude of Osteoarthritis disadVantage on pEoples liveS
NCT ID: NCT01423097
Last Updated: 2012-10-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1015 participants
OBSERVATIONAL
2011-09-30
2011-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)
* Characterization of OA diagnosis in patients with self-reported OA
* Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)
* Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA
* Patient perception of impact of OA in its life and importance given to disease
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Queluz Baixo, Barcarena, Portugal
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-RPO-XXX-2011/2
Identifier Type: -
Identifier Source: org_study_id